Non-FDA Generated Presentations for the March 5-6 2018 Risk Communication Advisory Committee Meeting
Physicians’ Perspective of the New Pregnancy and Lactation Labeling: Survey Results
Jennifer A. Namazy, M.D.
Communicating Risk in an Environment of Uncertainty
Michael F. Greene, M.D.
Prescribing for Pregnant Psychiatric Patients: Progress Report
Katherine L. Wisner, M.S., M.D.
Communicating Teratogen Information Effectively: The Teratogen Information Service (TIS) Perspective
Elizabeth Conover, M.S., APRN
Pregnancy and Lactation Labeling: A Law and Ethics Perspective
Kayte Spector-Bagdady, J.D., MBioethics
Pregnancy and Lactation Labeling Rule (PLLR) from an Industry Perspective
Traci J. Lee, Pharm.D.